Cholangiocarcinoma: A diagnostic dilemma on cytology - Shamsuddin - 2022 - Cytopathology - Wiley Online Library
Surface Markers of Cancer Stem Cells in Cholangiocarcinoma (CCA). | Download Scientific Diagram
Phenotype markers of candidate cholangiocarcinoma cells of origin | Download Table
Intrahepatic cholangiocarcinoma: Molecular markers for diagnosis and prognosis - ScienceDirect
Prognostic significance of epithelial–mesenchymal transition-related markers in extrahepatic cholangiocarcinoma: comprehensive immunohistochemical study using a tissue microarray | British Journal of Cancer
Frontiers | Emergence of Intrahepatic Cholangiocarcinoma: How High-Throughput Technologies Expedite the Solutions for a Rare Cancer Type
Frontiers | Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology
![PDF] Current insights on cholangiocarcinoma research: a brief review. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2b78b9b84e3159a5c89cfbb5afc01969c3b8a633/5-Table1-1.png "PDF] Current insights on cholangiocarcinoma research: a brief review. | Semantic Scholar")
PDF] Current insights on cholangiocarcinoma research: a brief review. | Semantic Scholar
Targeting cancer stem cells in cholangiocarcinoma (Review)
Cancers | Free Full-Text | Next-Generation Biomarkers for Cholangiocarcinoma
Biliary Tract Cancers | NEJM
IJMS | Free Full-Text | In Vivo Models for Cholangiocarcinoma—What Can We Learn for Human Disease?
Expression of Molecular Differentiation Markers Does Not Correlate with Histological Differentiation Grade in Intrahepatic Cholangiocarcinoma | PLOS ONE
Greta Evaristo, MD on Twitter: "Beware of arg-1 negative/ck19+ poorly differentiated intrahepatic neoplasms - distinguishing HCC vs. cholangiocarcinoma is ❗️critical ❗️ 👉🏽When Dr @sankakar 's 2-marker (& more) approach fails, genetic profile
Tumor marker analysis in the cases with and without cholangiocarcinoma | Download Table
POR | FOXF1 as an Immunohistochemical Marker of Hilar Cholangiocarcinoma or Metastatic Pancreatic Ductal Adenocarcinoma. Single Institution Experience
Biomarkers of intrahepatic cholangiocarcinoma: diagnosis and response to therapy
Annexin A1: A new immunohistological marker of cholangiocarcinoma
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions | Gut
What is Intrahepatic Cholangiocarcinoma (iCCA)? | FGFRscience.com
Understanding Cholangiocarcinoma - YouTube
Diagnostic and prognostic biomarkers in cholangiocarcinoma - Macias - 2019 - Liver International - Wiley Online Library
Peptidase inhibitor 15 as a novel blood diagnostic marker for cholangiocarcinoma - eBioMedicine
